Cargando…
Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
Brain metastases (BMs) are the most common type of brain tumor, and the incidence among breast cancer (BC) patients has been steadily increasing over the past two decades. Indeed, ~ 30% of all patients with metastatic BC will develop BMs, and due to few effective treatments, many will succumb to the...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8568876/ https://www.ncbi.nlm.nih.gov/pubmed/34716900 http://dx.doi.org/10.1007/s13346-021-01039-9 |